[HTML][HTML] The extracellular matrix and biocompatible materials in glioblastoma treatment

A Belousov, S Titov, N Shved, M Garbuz… - … in bioengineering and …, 2019 - frontiersin.org
During cancer genesis, the extracellular matrix (ECM) in the human brain undergoes
important transformations, starting to resemble embryonic brain cell milieu with a much …

[HTML][HTML] Biomaterials: Emerging systems for study and treatment of glioblastoma

JR Aguilera-Márquez, GT de Dios-Figueroa… - Neurology …, 2022 - Elsevier
Introduction Glioblastoma (GBM), the most frequent type of brain tumour in adults, is highly
aggressive and invasive. No curative treatment is currently available for GBM; patient …

Biomaterials developments for brain tissue engineering

EP Oliveira, J Silva-Correia, RL Reis… - Cutting-Edge Enabling …, 2018 - Springer
Abstract The Central Nervous System (CNS) is a highly complex organ that works as the
control centre of the body, managing vital and non-vital functions. Neuro-diseases can lead …

[HTML][HTML] The extracellular matrix in glioblastomas: a glance at its structural modifications in shaping the tumoral microenvironment—a Systematic review

S Marino, G Menna, R Di Bonaventura, L Lisi… - Cancers, 2023 - mdpi.com
Simple Summary The new trends in the research on glioblastomas (GBMs) are focusing on
understanding the crosstalk between proper neoplastic tissue and its microenvironment …

[HTML][HTML] Development of bioactive materials for glioblastoma therapy

J Yang, Y Li, T Zhang, X Zhang - Bioactive Materials, 2016 - Elsevier
Glioblastoma is the most common and deadly human brain cancers. Unique barriers hinder
the drug delivering pathway due to the individual position of glioblastoma, including blood …

[HTML][HTML] Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches

E Mohiuddin, H Wakimoto - American journal of cancer research, 2021 - ncbi.nlm.nih.gov
Extracellular matrix is a complex network of macromolecules that constitute a
microenvironment of normal tissues and malignancies such as the primary brain tumor …

Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery

Z Nozhat, S Heydarzadeh, M Shahriari-Khalaji… - Biomaterials …, 2023 - pubs.rsc.org
Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-
stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs …

[HTML][HTML] Microenvironmental rigidity of 3D scaffolds and influence on glioblastoma cells: a biomaterial design perspective

IE Palamà, S D'Amone, B Cortese - Frontiers in bioengineering and …, 2018 - frontiersin.org
Glioblastoma (GBM), or grade IV glioma, is an extremely aggressive tumor that infiltrates
through the brain leaving the patient with a median survival time from 12 to 15 months …

Polymeric biomaterial scaffolds for tumoricidal stem cell glioblastoma therapy

KM Moore, AB Murthy, EG Graham-Gurysh… - ACS biomaterials …, 2020 - ACS Publications
Glioblastoma (GBM) is the most common primary brain tumor and has a poor prognosis; as
such, there is an urgent need to develop innovative new therapies. Tumoricidal stem cells …

[HTML][HTML] Biomaterials in neurodegenerative disorders: a promising therapeutic approach

M Bordoni, E Scarian, F Rey, S Gagliardi… - International journal of …, 2020 - mdpi.com
Neurodegenerative disorders (ie, Alzheimer's disease, Parkinson's disease, amyotrophic
lateral sclerosis, and spinal cord injury) represent a great problem worldwide and are …